FDA’s Approval of Breakthrough NASH Treatment Opens Door for a Long-Neglected Patient Population
March 14, 2024 17:18 ET
|
Global Liver Institute
Washington, DC, March 14, 2024 (GLOBE NEWSWIRE) -- Today, Global Liver Institute (GLI) recognizes the importance of the first approval by the U.S. Food and Drug Administration (FDA) of a medication...
For Rare Liver Disease Patients, Care Transitions Pose Yet Another Risk
February 01, 2024 08:00 ET
|
Global Liver Institute
Washington, D.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Today marks the start of Global Liver Institute’s (GLI) 2024 #RareAware campaign, which calls attention to the more than 100 rare liver diseases...
Doctors and Experts around the World Call for Urgent Action to Prevent Liver Health Crisis
December 12, 2023 15:21 ET
|
Global Liver Institute
Washington D.C., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating globally, released the second edition of its “Global State...
Global Communities Rally around Third Deadliest Cancer – Liver Cancer
October 01, 2023 10:30 ET
|
Global Liver Institute
Washington, DC, Oct. 01, 2023 (GLOBE NEWSWIRE) -- Today marks the start of Liver Cancer Awareness Month, which will feature the monthlong #OctoberIs4Livers multifaceted campaign led by Global Liver...
Growth in Patient and Medical Community Engagement in NASH Community Persists Despite Recent Regulatory Disappointment
June 08, 2023 07:19 ET
|
Global Liver Institute
Washington, D.C., June 08, 2023 (GLOBE NEWSWIRE) -- Today is International NASH Day, a time where healthcare experts and community members around the globe step up and raise awareness of the most...
ICER MIDWEST CEPAC WORKS TO KEEP UP WITH WELL-INFORMED NASH PATIENT ADVOCATES
May 01, 2023 17:36 ET
|
Global Liver Institute
Washington, DC, May 01, 2023 (GLOBE NEWSWIRE) -- On Friday, the Institute for Clinical and Economic Review (ICER) held a public hearing to review its draft assessment of Resmetirom and Obeticholic...
PATIENT GROUPS DECLARE ICER REVIEW OF NASH MEDICATIONS CAUSES MORE UNCERTAINTY AND CONTROVERSIES THAN IT RESOLVES
April 28, 2023 12:22 ET
|
Global Liver Institute
Washington, DC, April 28, 2023 (GLOBE NEWSWIRE) -- Today, the Institute for Clinical and Economic Review (ICER) will hold a public hearing on its draft assessment of Resmetirom and Obeticholic Acid...
Obstetric and Neonatal Professionals Must Work More Closely with Pregnant People to Identify Liver Diseases Early
February 01, 2023 11:11 ET
|
Global Liver Institute
Washington, D.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) launches its third annual #RareAware campaign today to raise awareness of and build resources for liver health...
If We Do Not Prevent Liver Disease Now, the World Will Face Devastating Loss of Both Life and Financial Resources
November 03, 2022 10:53 ET
|
Global Liver Institute
Washington, D.C., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating globally, announces the launch of its Global State of Liver...
Global Liver Institute Recognized as a Healthy People 2030 Champion
October 04, 2022 17:08 ET
|
Global Liver Institute
Washington, D.C., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating worldwide, announces that the Office of Disease Prevention...